Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2000
12/21/2000CA2376675A1 Antagonists of bmp and tgf.beta. signalling pathways
12/21/2000CA2376667A1 Gene expression modulated in gastrointestinal inflammation
12/21/2000CA2376487A1 Methods for enhancing the production of cytokines in cell culture
12/21/2000CA2376467A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production
12/21/2000CA2376446A1 Nucleic acid fragment and vector containing halogenase and method for the halogenation of chemical compounds
12/21/2000CA2376421A1 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000CA2376394A1 Retro-inverso peptides derived from interleukin-3
12/21/2000CA2376392A1 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells
12/21/2000CA2376389A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000CA2376288A1 Use of antibodies against cd20 for the treatment of the graft versus host disease
12/21/2000CA2376243A1 Gustatory receptors in drosophila
12/21/2000CA2375998A1 Gene and protein sequences of phage t4 gene 35
12/21/2000CA2375825A1 Complement-resistant non-mammalian dna viruses and uses thereof
12/21/2000CA2375386A1 Lipocalin family protein
12/21/2000CA2374909A1 Human intracellular signaling molecules
12/21/2000CA2373628A1 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism
12/21/2000CA2370405A1 Nucleic acid molecules from wheat, transgenic plant cells and plants and the use thereof for the production of modified starch
12/20/2000EP1060260A2 Elongation factor-2 kinase (ef-2 kinase) and methods of use therefor
12/20/2000EP1060259A2 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
12/20/2000EP1060257A1 Method for the induction of pathogen resistance in plants
12/20/2000EP1060255A2 Highly crystalline urokinase
12/20/2000EP1060254A2 Human proteinase molecules
12/20/2000EP1060252A2 Human platelet heparanase polypeptides, polynucleotide molecules that encode them, and methods for the identification of compounds that alter heparanase activity
12/20/2000EP1060251A2 Phosphodiesterase 10
12/20/2000EP1060250A1 Modification of fatty acid metabolism in plants
12/20/2000EP1060248A1 Lectomedin materials and methods
12/20/2000EP1060245A2 Human spinal cord cell lines and methods of use therefor
12/20/2000EP1060244A1 Pluripotent embryonic stem cells and methods of obtaining them
12/20/2000EP1060242A1 Purified populations of stem cells
12/20/2000EP1060241A1 Preparation of cells for production of biologicals
12/20/2000EP1060238A1 Culture dish
12/20/2000EP1060185A1 Isolated nucleic acid molecules which encode tage molecules, and uses thereof
12/20/2000EP1060184A1 Best's macular dystrophy gene
12/20/2000EP1059931A2 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
12/20/2000EP1059929A2 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/20/2000EP0877555A4 Method of inhibiting immune system destruction of transplanted viable cells
12/20/2000EP0823848A4 Tissue adhesive using synthetic cross-linking
12/20/2000CN1277631A Suspension packing cell lines for retrovirus vectors
12/20/2000CN1277616A Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor
12/20/2000CN1059705C Composition for introducing nucleic acid complexes into higher eucaryotic cells
12/20/2000CN1059704C Anti-diseases perfume tobacco cultured by gene engineering method
12/20/2000CN1059702C Method for cerebral acetylcholinesterase obtained from cells of mamma animals
12/20/2000CN1059701C Donkey leukocyte hypotoxic strain for equine infection anemia and its culture method
12/19/2000US6162966 Transgenic plant cell exhibiting reduced disproportionating enzyme activity due to presence of exogenous dna which deactivates the endogenous enzyme; increased phosphate content of starch
12/19/2000US6162902 Reactive to epitopes of human brain natriuretic peptide; rapid and sensitive quantification in plasma or serum
12/19/2000US6162643 Serum-free mixture of 2-(4-(2-hydroxyethyl)piperazinyl) ethanesulfonic acid at concentration of 16-22 mm, sodium chloride at 90-140 mm, and a protease; for production of epithelial tissues like epidermis, cornea, gingiva and ureter
12/19/2000US6162618 Nucleotide sequence; recombinant production; diagnosis of infections; drug screening; bactericides; bacteriostats; enzyme inhibitors; vaccines
12/19/2000US6162612 Enzymatic polypeptide; for te detection of enzyme inhibitor which can be used to treat cancer, psoriasis and vascular system defects; anticarcinogenic agents
12/19/2000US6162461 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
12/19/2000US6162431 Serine/threonine protein kinase
12/19/2000US6162428 hNT-neuron human neuronal cells to replace ganglion cells
12/19/2000CA2053206C Monoclonal antibodies against melanoma
12/19/2000CA1341158C Octopine t-dna promoters
12/14/2000WO2000075376A1 Hepg2 cells stably transfected with hcv
12/14/2000WO2000075375A1 26 human secreted proteins
12/14/2000WO2000075365A2 Compounds and methods to enhance raav transduction
12/14/2000WO2000075353A1 Compositions and methods useful for production of recombinant viruses which require helper viruses
12/14/2000WO2000075350A2 Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
12/14/2000WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof
12/14/2000WO2000075347A2 Tet repressor-based transcriptional regulatory proteins
12/14/2000WO2000075341A1 Δ6-acetylenase and δ6-desaturase from ceratodon purpureus
12/14/2000WO2000075339A1 Substrate trapping protein tyrosine phosphatases
12/14/2000WO2000075335A2 Bacteriophage rm 378 of a thermophilic host organism
12/14/2000WO2000075333A1 Streptavidin expressed gene fusions and methods of use thereof
12/14/2000WO2000075331A1 Compositions affecting programmed cell death and their use in the modification of forestry plant development
12/14/2000WO2000075330A1 Use of the bnm3 transcriptional activator to control plant embryogenesis and regeneration processes
12/14/2000WO2000075328A1 Human sel-10 polypeptides and polynucleotides that encode them
12/14/2000WO2000075323A1 Tek antagonists
12/14/2000WO2000075322A1 Insect monoamine transporter and methods of use thereof
12/14/2000WO2000075319A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075317A2 Compositions and methods for the treatment of tumor
12/14/2000WO2000075311A1 Recombinant nematode nicotinic receptor and uses
12/14/2000WO2000075309A1 Spliceosome protein and its use
12/14/2000WO2000075300A2 Methods for manipulating the avian genome
12/14/2000WO2000075291A2 Cells with enforced expression of bcl-xl
12/14/2000WO2000075290A1 Method for multiplying stem cells
12/14/2000WO2000075288A1 Transgenic decapods, decapod cell lines and methods of producing same
12/14/2000WO2000075287A2 Long term cell culture of human carcinoma
12/14/2000WO2000075286A2 3-dimensional in vitro models of mammaliam tissues
12/14/2000WO2000075279A2 Nucleotide sequences for gene regulation and methods of use thereof
12/14/2000WO2000075278A2 Gene encoding nade, p75ntr-associated cell death executor and uses thereof
12/14/2000WO2000075190A2 Hybridomas for lung cancer marker and monoclonal antibodies thereof
12/14/2000WO2000075187A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000WO2000075176A1 Small cyclic mimics of brain-derived neurotrophic factor (bdnf)
12/14/2000WO2000075175A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000WO2000075170A1 Mutant fatty acid desaturase and methods for directed mutagenesis
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000074741A2 Biological joint construct
12/14/2000WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000WO2000074584A1 Devices and methods for treating tissue
12/14/2000WO2000074483A1 Improved storage and maintenance of blood products including red blood cells and platelets
12/14/2000WO2000055355A3 Method of screening candidate compounds for susceptibility to biliary excretion
12/14/2000WO2000050570A3 Compositions and methods for modulating growth or differentiation of growth-factor dependent cells
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000049141A3 A method for production and delivery of a protein in vivo
12/14/2000WO2000049135A3 Substrate for cell growth
12/14/2000WO2000049040A3 Antimicrobial/endotoxin neutralizing polypeptide
12/14/2000WO2000049039A3 Glucose dehydrogenase fusion proteins and their utilization in expression systems
12/14/2000WO2000047716A3 Fibres for culturing eukaryotic cells
1 ... 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 ... 1827